Format
Sort by

Send to

Choose Destination

Selected items

Items: 20

1.

Utility of QuantiFERON®-TB Gold test in diagnosis and management of suspected tubercular uveitis in India.

Sudharshan S, Ganesh SK, Balu G, Mahalakshmi B, Therese LK, Madhavan HN, Biswas J.

Int Ophthalmol. 2012 Jun;32(3):217-23. doi: 10.1007/s10792-012-9554-0.

PMID:
22527447
2.

QuantiFERON®-TB gold in-tube performance for diagnosing active tuberculosis in children and adults in a high burden setting.

Rose MV, Kimaro G, Nissen TN, Kroidl I, Hoelscher M, Bygbjerg IC, Mfinanga SG, Ravn P.

PLoS One. 2012;7(7):e37851. doi: 10.1371/journal.pone.0037851.

3.

Predictors of discordant tuberculin skin test and QuantiFERON®-TB Gold In-Tube results in various high-risk groups.

Weinfurter P, Blumberg HM, Goldbaum G, Royce R, Pang J, Tapia J, Bethel J, Mazurek GH, Toney S, Albalak R; Tuberculosis Epidemiological Studies Consortium..

Int J Tuberc Lung Dis. 2011 Aug;15(8):1056-61. doi: 10.5588/ijtld.10.0650.

PMID:
21740668
4.
5.

Use of Quantiferon-TB-Gold in Tube(®) test for detecting latent tuberculosis in patients considered as candidates for anti-TNF therapy in routine clinical practice.

García-Gasalla M, Fernández-Baca V, Juan-Mas A, Payeras-Cifre A, Cifuentes-Luna C, Taberner-Ferrer R, Riera-Oliver J, Ros-Villamajó I, Navarro-Fernández V, Morey Torrandell C, Gallegos-Alvarez C, Mir-Villadrich I.

Enferm Infecc Microbiol Clin. 2013 Feb;31(2):76-81. doi: 10.1016/j.eimc.2012.06.014.

PMID:
22902246
6.

Observational study of QuantiFERON®-TB gold in-tube assay in tuberculosis contacts in a low incidence area.

Bergot E, Haustraete E, Malbruny B, Magnier R, Salaün MA, Zalcman G.

PLoS One. 2012;7(8):e43520. doi: 10.1371/journal.pone.0043520.

7.

QuantiFERON®-TB Gold In-Tube assay vs. tuberculin skin test in Indonesian children living with a tuberculosis case.

Rutherford ME, Nataprawira M, Yulita I, Apriani L, Maharani W, van Crevel R, Hill PC, Alisjahbana B.

Int J Tuberc Lung Dis. 2012 Apr;16(4):496-502. doi: 10.5588/ijtld.11.0491.

PMID:
22325792
8.

Indeterminate QuantiFERON®-TB Gold results in a public health clinic setting.

Banach DB, Harris TG.

Int J Tuberc Lung Dis. 2011 Dec;15(12):1623-30. doi: 10.5588/ijtld.11.0017.

PMID:
22118169
9.

[Comparative performance of QuantiFERON(®)-TB Gold IT versus tuberculin skin test among contact investigations for latent tuberculosis infection].

Delgado Naranjo J, Castells Carrillo C, García Calabuig MÁ, Sáez López I; en representación del Grupo de Trabajo para el estudio de los IGRAS en Bizkaia y Araba (GTIBA)..

Med Clin (Barc). 2011 Sep 17;137(7):289-96. doi: 10.1016/j.medcli.2010.11.036. Spanish.

PMID:
21524761
10.

The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa.

Mahomed H, Hawkridge T, Verver S, Abrahams D, Geiter L, Hatherill M, Ehrlich R, Hanekom WA, Hussey GD.

PLoS One. 2011 Mar 29;6(3):e17984. doi: 10.1371/journal.pone.0017984. Erratum in: PLoS One. 2011;6(6). doi:10.1371/annotation/b371be66-de38-4ed6-b440-d27c9d7e552c.

11.

Quantitative and qualitative QuantiFERON(®)-TB gold in-tube results among groups with varying risks of exposure to tuberculosis.

Simpson T, Fox J, Crouse K, Field K.

Heart Lung. 2012 Nov-Dec;41(6):553-61. doi: 10.1016/j.hrtlng.2012.06.005.

PMID:
22840377
12.

Clinical experience of QuantiFERON(®) -TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan.

Chiu HY, Hsueh PR, Tsai TF.

Br J Dermatol. 2011 Mar;164(3):553-9. doi: 10.1111/j.1365-2133.2010.10137.x.

PMID:
21083541
13.

Application of the QuantiFERON®-TB Gold test in erythema induratum.

Sim JH, Whang KU.

J Dermatolog Treat. 2014 Jun;25(3):260-3. doi: 10.3109/09546634.2012.699178.

PMID:
22920648
14.

Role of the QuantiFERON(R)-TB Gold In-Tube assay in screening new immigrants for tuberculosis infection.

Mulder C, van Deutekom H, Huisman EM, Toumanian S, Koster BF, Meijer-Veldman W, van Loenhout-Rooyackers JH, Appel M, Arend SM, Borgdorff MW, van Leth F.

Eur Respir J. 2012 Dec;40(6):1443-9. doi: 10.1183/09031936.00010612.

15.

Diagnostic value of interferon- gamma release assays (QuantiFERON-TB Gold® In Tube) in childhood tuberculosis.

Dayal R, Verma V, Sharma B, Kumar G, Kumar N, Gupta R, Katoch VM, Joshi B, Chauhan DS.

Indian J Pediatr. 2012 Feb;79(2):183-7. doi: 10.1007/s12098-011-0469-y.

PMID:
21706246
16.

Cost-effectiveness of Quantiferon®-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil.

Steffen RE, Caetano R, Pinto M, Chaves D, Ferrari R, Bastos M, de Abreu ST, Menzies D, Trajman A.

PLoS One. 2013 Apr 4;8(4):e59546. doi: 10.1371/journal.pone.0059546.

17.

[Analysis of discordance between tuberculin test and QuantiFERON-TB® Gold In-Tube in studies of contacts].

Ballaz A, Salinas C, Aguirre U, López de Goicoechea MJ, Diez R, Egurrola M.

Med Clin (Barc). 2013 Apr 15;140(7):289-95. doi: 10.1016/j.medcli.2012.09.041. Spanish.

PMID:
23339888
18.

Medium-throughput SNP genotyping using mass spectrometry: multiplex SNP genotyping using the iPLEX® Gold assay.

Millis MP.

Methods Mol Biol. 2011;700:61-76. doi: 10.1007/978-1-61737-954-3_5.

PMID:
21204027
19.

Serial testing of Malaysian health care workers with QuantiFERON®-TB Gold In-Tube.

Rafiza S, Rampal KG.

Int J Tuberc Lung Dis. 2012 Feb;16(2):163-8. doi: 10.5588/ijtld.11.0364.

PMID:
22236915
20.

Glutathione-mediated release of Bodipy® from PEG cofunctionalized gold nanoparticles.

Kumar D, Meenan BJ, Dixon D.

Int J Nanomedicine. 2012;7:4007-22. doi: 10.2147/IJN.S33726.

Items per page

Supplemental Content

Support Center